FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:LRRC1-HSP90AB1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: LRRC1-HSP90AB1
FusionPDB ID: 49880
FusionGDB2.0 ID: 49880
HgeneTgene
Gene symbol

LRRC1

HSP90AB1

Gene ID

55227

3326

Gene nameleucine rich repeat containing 1heat shock protein 90 alpha family class B member 1
SynonymsLANO|dJ523E19.1D6S182|HSP84|HSP90B|HSPC2|HSPCB
Cytomap

6p12.1

6p21.1

Type of geneprotein-codingprotein-coding
Descriptionleucine-rich repeat-containing protein 1LANO adapter proteinLAP (leucine-rich repeats and PDZ) and no PDZ proteinLAP and no PDZ proteinheat shock protein HSP 90-betaHSP90-betaheat shock 84 kDaheat shock 90kD protein 1, betaheat shock protein 90 kDaheat shock protein 90kDa alpha (cytosolic), class B member 1heat shock protein 90kDa alpha family class B member 1
Modification date2020031320200327
UniProtAcc

Q9H756

Main function of 5'-partner protein: FUNCTION: Pathogen-recognition receptor which mediates the activation of TRAF2- and TRAF6 NF-kappa-B signaling pathways and induces the expression of proinflammatory cytokines (PubMed:19679103, PubMed:25026888). In kidney, prevents infection by uropathogenic bacteria by inducing the production of cytokines, chemokines and antimicrobial substances. In gut, involved in host-microbiota interactions, plays a critical role in promoting the recruitment of immune cells and intestinal inflammation (By similarity). {ECO:0000250|UniProtKB:Q8BZT5, ECO:0000269|PubMed:19679103, ECO:0000269|PubMed:25026888}.

P08238

Main function of 5'-partner protein: FUNCTION: Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function (PubMed:16478993, PubMed:19696785). Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself. Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle (PubMed:27295069, PubMed:26991466). Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels. They first alter the steady-state levels of certain transcription factors in response to various physiological cues. Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment. Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression (PubMed:25973397). Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation (PubMed:24613385). Promotes cell differentiation by chaperoning BIRC2 and thereby protecting from auto-ubiquitination and degradation by the proteasomal machinery (PubMed:18239673). Main chaperone involved in the phosphorylation/activation of the STAT1 by chaperoning both JAK2 and PRKCE under heat shock and in turn, activates its own transcription (PubMed:20353823). Involved in the translocation into ERGIC (endoplasmic reticulum-Golgi intermediate compartment) of leaderless cargos (lacking the secretion signal sequence) such as the interleukin 1/IL-1; the translocation process is mediated by the cargo receptor TMED10 (PubMed:32272059). {ECO:0000269|PubMed:16478993, ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:19696785, ECO:0000269|PubMed:20353823, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:32272059, ECO:0000303|PubMed:25973397, ECO:0000303|PubMed:26991466, ECO:0000303|PubMed:27295069}.
Ensembl transtripts involved in fusion geneENST idsENST00000370882, ENST00000370888, 
ENST00000353801, ENST00000371554, 
ENST00000371646, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score8 X 4 X 7=22417 X 17 X 9=2601
# samples 1120
** MAII scorelog2(11/224*10)=-1.02599520853294
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(20/2601*10)=-3.70099449416827
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: LRRC1 [Title/Abstract] AND HSP90AB1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: LRRC1 [Title/Abstract] AND HSP90AB1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)LRRC1(53660213)-HSP90AB1(44216367), # samples:2
Anticipated loss of major functional domain due to fusion event.LRRC1-HSP90AB1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
LRRC1-HSP90AB1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
LRRC1-HSP90AB1 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF.
LRRC1-HSP90AB1 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneHSP90AB1

GO:0007004

telomere maintenance via telomerase

10197982

TgeneHSP90AB1

GO:0030511

positive regulation of transforming growth factor beta receptor signaling pathway

24613385

TgeneHSP90AB1

GO:0031396

regulation of protein ubiquitination

16809764

TgeneHSP90AB1

GO:0032435

negative regulation of proteasomal ubiquitin-dependent protein catabolic process

24613385

TgeneHSP90AB1

GO:0032516

positive regulation of phosphoprotein phosphatase activity

26593036

TgeneHSP90AB1

GO:0051131

chaperone-mediated protein complex assembly

10811660

TgeneHSP90AB1

GO:0051973

positive regulation of telomerase activity

10197982

TgeneHSP90AB1

GO:1901389

negative regulation of transforming growth factor beta activation

20599762

TgeneHSP90AB1

GO:1905323

telomerase holoenzyme complex assembly

10197982

TgeneHSP90AB1

GO:2000010

positive regulation of protein localization to cell surface

23431407



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr6:53660213/chr6:44216367)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across LRRC1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across HSP90AB1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000370888LRRC1chr653660213+ENST00000371646HSP90AB1chr644216367+28964362772610777
ENST00000370888LRRC1chr653660213+ENST00000371554HSP90AB1chr644216367+28964362772610777
ENST00000370882LRRC1chr653660213+ENST00000371646HSP90AB1chr644216367+27863261672500777
ENST00000370882LRRC1chr653660213+ENST00000371554HSP90AB1chr644216367+27863261672500777

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000370888ENST00000371646LRRC1chr653660213+HSP90AB1chr644216367+0.005865550.9941345
ENST00000370888ENST00000371554LRRC1chr653660213+HSP90AB1chr644216367+0.005865550.9941345
ENST00000370882ENST00000371646LRRC1chr653660213+HSP90AB1chr644216367+0.0059516330.99404836
ENST00000370882ENST00000371554LRRC1chr653660213+HSP90AB1chr644216367+0.0059516330.99404836

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for LRRC1-HSP90AB1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
LRRC1chr653660213HSP90AB1chr64421636732648RSLEELLLDANQLRELPEMPEEVHHG
LRRC1chr653660213HSP90AB1chr64421636743648RSLEELLLDANQLRELPEMPEEVHHG

Top

Potential FusionNeoAntigen Information of LRRC1-HSP90AB1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
LRRC1-HSP90AB1_53660213_44216367.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B39:01NQLRELPEM0.96340.91681019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B39:13NQLRELPEM0.92230.91361019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B13:01NQLRELPEM0.91890.86121019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A74:11LLLDANQLR0.90580.9248514
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A74:03LLLDANQLR0.90580.9248514
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A74:09LLLDANQLR0.90580.9248514
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:21NQLRELPEM0.71710.52621019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A68:03ELLLDANQLR0.94690.6668414
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A68:05ELLLDANQLR0.92470.6757414
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:67LLLDANQLREL0.99880.6694516
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:30LLLDANQLREL0.99880.6694516
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:24LLLDANQLREL0.99880.6694516
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:60LLLDANQLREL0.99870.6877516
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:04LLLDANQLREL0.99860.8751516
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:17LLLDANQLREL0.99840.7246516
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:16LLLDANQLREL0.9980.6441516
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:19LLLDANQLREL0.99560.7049516
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:29LLLDANQLREL0.94490.6724516
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:20LLLDANQLREL0.92150.6795516
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B51:07DANQLREL0.99920.754816
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B39:09NQLRELPEM0.9810.68351019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B15:21NQLRELPEM0.93090.8031019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B39:05NQLRELPEM0.90570.90751019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-C05:09LLDANQLREL10.9502616
LRRC1-HSP90AB1chr653660213chr644216367326HLA-C08:15LLDANQLREL0.99990.9645616
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:07LLDANQLREL0.97010.7324616
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:02LLLDANQLREL0.99960.6567516
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:01LLLDANQLREL0.99880.6694516
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:07LRELPEMPEEV0.91210.73171223
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B39:02NQLRELPEM0.97140.91881019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B39:31NQLRELPEM0.96970.91731019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A74:01LLLDANQLR0.90580.9248514
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B15:73NQLRELPEM0.90350.81811019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B35:20NQLRELPEM0.81540.87361019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B35:28NQLRELPEM0.80110.86261019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B39:11NQLRELPEM0.79660.75741019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B18:04NQLRELPEM0.76190.85821019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B48:02NQLRELPEM0.75830.84441019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-A02:06NQLRELPEM0.71710.52621019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-B15:09NQLRELPEM0.51850.50711019
LRRC1-HSP90AB1chr653660213chr644216367326HLA-C05:01LLDANQLREL10.9502616
LRRC1-HSP90AB1chr653660213chr644216367326HLA-C08:02LLDANQLREL0.99990.9645616

Top

Potential FusionNeoAntigen Information of LRRC1-HSP90AB1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
LRRC1-HSP90AB1_53660213_44216367.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0301LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0301SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0301RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0301EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0303LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0303EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0305LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0307LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0313LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0313SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0313RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0313EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0315LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0318LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0318SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0318RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0318EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0320LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0320SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0320EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0320RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0322LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0322SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0322RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0322EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0326LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0326SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0326RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0326EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0328LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0328SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0328RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0328EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0330LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0330SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0330RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0330EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0332LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0332SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0332RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0332EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0334LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0334SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0334RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0334EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0336LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0336SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0336RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0336EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0342LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0342SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0342RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0342EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0344LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0344SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0344RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0344EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0346LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0346SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0346RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0346EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0348LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0348SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0348RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0348EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0350LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0350SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0350RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0350EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0352LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0352SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0352RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0352EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0354LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0354SLEELLLDANQLREL116
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0354RSLEELLLDANQLRE015
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-0354EELLLDANQLRELPE318
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-1107LEELLLDANQLRELP217
LRRC1-HSP90AB1chr653660213chr644216367326DRB1-1525LEELLLDANQLRELP217

Top

Fusion breakpoint peptide structures of LRRC1-HSP90AB1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
5201LLDANQLRELPEMPLRRC1HSP90AB1chr653660213chr644216367326

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of LRRC1-HSP90AB1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN5201LLDANQLRELPEMP-7.9962-8.1096
HLA-B14:023BVN5201LLDANQLRELPEMP-5.70842-6.74372
HLA-B52:013W395201LLDANQLRELPEMP-6.83737-6.95077
HLA-B52:013W395201LLDANQLRELPEMP-4.4836-5.5189
HLA-A11:014UQ25201LLDANQLRELPEMP-10.0067-10.1201
HLA-A11:014UQ25201LLDANQLRELPEMP-9.03915-10.0745
HLA-A24:025HGA5201LLDANQLRELPEMP-6.56204-6.67544
HLA-A24:025HGA5201LLDANQLRELPEMP-5.42271-6.45801
HLA-B44:053DX85201LLDANQLRELPEMP-7.85648-8.89178
HLA-B44:053DX85201LLDANQLRELPEMP-5.3978-5.5112
HLA-A02:016TDR5201LLDANQLRELPEMP-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of LRRC1-HSP90AB1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
LRRC1-HSP90AB1chr653660213chr6442163671019NQLRELPEMCTGCCCGAGATGCCTGAGGAAGTGCAC
LRRC1-HSP90AB1chr653660213chr6442163671223LRELPEMPEEVGAGATGCCTGAGGAAGTGCACCATGGAGAGGAG
LRRC1-HSP90AB1chr653660213chr644216367414ELLLDANQLRGCCAACCAGCTCCGCGAGCTGCCCGAGATG
LRRC1-HSP90AB1chr653660213chr644216367514LLLDANQLRAACCAGCTCCGCGAGCTGCCCGAGATG
LRRC1-HSP90AB1chr653660213chr644216367516LLLDANQLRELAACCAGCTCCGCGAGCTGCCCGAGATGCCTGAG
LRRC1-HSP90AB1chr653660213chr644216367616LLDANQLRELCAGCTCCGCGAGCTGCCCGAGATGCCTGAG
LRRC1-HSP90AB1chr653660213chr644216367816DANQLRELCGCGAGCTGCCCGAGATGCCTGAG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
LRRC1-HSP90AB1chr653660213chr644216367015RSLEELLLDANQLRECTGCTGCTGGACGCCAACCAGCTCCGCGAGCTGCCCGAGATGCCT
LRRC1-HSP90AB1chr653660213chr644216367116SLEELLLDANQLRELCTGCTGGACGCCAACCAGCTCCGCGAGCTGCCCGAGATGCCTGAG
LRRC1-HSP90AB1chr653660213chr644216367217LEELLLDANQLRELPCTGGACGCCAACCAGCTCCGCGAGCTGCCCGAGATGCCTGAGGAA
LRRC1-HSP90AB1chr653660213chr644216367318EELLLDANQLRELPEGACGCCAACCAGCTCCGCGAGCTGCCCGAGATGCCTGAGGAAGTG

Top

Information of the samples that have these potential fusion neoantigens of LRRC1-HSP90AB1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
MESOLRRC1-HSP90AB1chr653660213ENST00000370882chr644216367ENST00000371554TCGA-SC-A6LQ-01A

Top

Potential target of CAR-T therapy development for LRRC1-HSP90AB1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to LRRC1-HSP90AB1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to LRRC1-HSP90AB1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource